Medical Cannabis Payment Solutions (REFG) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMedical Cannabis Payment Solutions (REFG) trades at $0.0003. Medical Cannabis Payment Solutions, Inc. (REFG) operates in the healthcare sector, providing payment processing solutions for the medical cannabis industry. Sector: Healthcare.
Price as of · Last analyzed: Mar 15, 2026Analyst Coverage for REFG: REFG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Medical Cannabis Payment Solutions (REFG) Healthcare & Pipeline Overview
Medical Cannabis Payment Solutions, Inc. (REFG) offers payment processing solutions tailored for the medical cannabis industry, focusing on regulatory compliance and transaction oversight. Operating in the Healthcare Information Services sector, the company aims to streamline payment processes and enhance transparency in a rapidly evolving market.
What Is the Investment Thesis for REFG?
Investing in Medical Cannabis Payment Solutions, Inc. (REFG) presents a high-risk, high-reward scenario given its focus on the niche market of payment solutions for the medical cannabis industry. The company's success hinges on its ability to navigate complex regulatory landscapes and establish itself as a trusted payment processor. Key value drivers include the expansion of legal medical cannabis markets across the United States and the increasing demand for compliant payment solutions. However, potential investors should be aware of the risks associated with investing in OTC-listed companies and the uncertainties surrounding the cannabis industry. With a negative P/E ratio of -1.78 and a beta of -9.48, REFG exhibits significant volatility and speculative potential. The company's ability to secure partnerships with medical cannabis dispensaries and demonstrate revenue growth will be critical for long-term success.
Based on FMP financials and quantitative analysis
REFG Key Highlights
REFG operates in the niche market of payment solutions for the medical cannabis industry.
- The company's solution assists in state tracking of sales, tax collection, and supervision of sales to consumers.
- REFG is incorporated in 2013 and based in Cheyenne, Wyoming.
- The company has a market capitalization of $0.00B as of March 15, 2026.
- REFG has a negative P/E ratio of -1.78, indicating it is not currently profitable.
Who Are REFG's Competitors?
REFG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SCNX Scienture Holdings, Inc. | $3.69 | -7.05% | $6.45M | — |
| ACON Aclarion, Inc. | $2.34 | -1.68% | $6.86M | — |
| MGRX Mangoceuticals, Inc. | $0.42 | -4.14% | $7.42M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.59 | -4.45% | $11.5M | — |
| BEAT HeartBeam, Inc. | $0.70 | +60.54% | $24.1M | — |
| ONMD OneMedNet Corporation | $5.35 | -0.74% | $30.7M | — |
| EUDA EUDA Health Holdings Limited | $17.68 | +2.57% | $32.2M | — |
| CCLD CareCloud, Inc. | $2.08 | +3.22% | $85.8M | 68 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are REFG's Key Strengths?
Specialized payment solution for the medical cannabis industry.
- Focus on regulatory compliance.
- Potential for first-mover advantage.
- Proprietary technology.
What Are REFG's Weaknesses?
Small company with limited resources (1 employee).
- Dependence on the growth of the medical cannabis market.
- Negative P/E ratio indicates lack of profitability.
- OTC listing may limit access to capital.
What Are the Key Risks for REFG?
Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
- Increasing competition from established payment processors.
- Changes in regulations that could impact the medical cannabis industry.
- Negative public perception of cannabis.
- Difficulty attracting and retaining talent.
- Limited financial resources and lack of profitability.
What Are REFG's Competitive Advantages?
- Specialized Expertise: REFG has developed expertise in the unique regulatory and compliance requirements of the medical cannabis industry.
- First-Mover Advantage: As an early entrant into the market, REFG may have established relationships with dispensaries and gained a competitive edge.
- Proprietary Technology: REFG's payment system may incorporate proprietary technology that provides a competitive advantage.
- Regulatory Compliance: REFG's focus on compliance can be a significant differentiator in a highly regulated industry.
What Does REFG Do?
Medical Cannabis Payment Solutions, Inc., incorporated in 2013 and based in Cheyenne, Wyoming, develops and markets a payment system designed specifically for medical cannabis transactions. The company's solution is intended to assist in the state tracking of sales, collection of taxes, and supervision of sales to consumers, addressing the unique regulatory and compliance challenges within the medical cannabis industry. REFG's core offering aims to provide a secure and transparent payment processing platform that facilitates compliance with state regulations governing the sale and distribution of medical cannabis. The company's focus is on bridging the gap between the growing medical cannabis market and the need for reliable, compliant payment solutions. As of 2026, the company is managed by Jeremy Roberts and has one employee.
What Products and Services Does REFG Offer?
- Develops a payment system for medical cannabis transactions.
- Markets the payment system to medical cannabis dispensaries.
- Assists in the state tracking of cannabis sales.
- Facilitates the collection of taxes on cannabis sales.
- Supervises sales to consumers to ensure compliance.
- Provides a secure and transparent payment processing platform.
How Does REFG Make Money?
- REFG generates revenue by charging transaction fees on medical cannabis payments processed through its system.
- The company may also offer subscription-based services to dispensaries for access to its payment platform and compliance tools.
- REFG could potentially generate revenue through data analytics services, providing insights into sales trends and consumer behavior.
What Industry Does REFG Operate In?
Medical Cannabis Payment Solutions, Inc. operates within the rapidly evolving medical cannabis industry, which is experiencing significant growth due to increasing legalization and acceptance. The market demands secure and compliant payment solutions to facilitate transactions and ensure regulatory compliance. REFG aims to address this need by providing a specialized payment system for medical cannabis transactions. The competitive landscape includes companies offering similar payment processing services, as well as traditional financial institutions that may be hesitant to enter the cannabis market due to regulatory concerns. Competitors include ABMT, CBGL, DNAG, IMMB, and IPAH. The company's success depends on its ability to differentiate itself through superior technology, compliance expertise, and strong relationships with medical cannabis dispensaries.
Who Are REFG's Key Customers?
- Medical cannabis dispensaries that require a compliant payment processing solution.
- Patients who purchase medical cannabis and need a secure way to pay.
- State governments that need to track cannabis sales and collect taxes.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Medical Cannabis Payment Solutions operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Cheyenne, US. REFG has traded publicly since 1998.
Financial Health
Medical Cannabis Payment Solutions's Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
REFG Financials
REFG Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
REFG Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for REFG.
Price Targets
Wall Street price target analysis for REFG.
REFG MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for REFG; grades run from A+ (80-100) to F (below 30).
Leadership: Jeremy Roberts
Managing
Jeremy Roberts currently manages Medical Cannabis Payment Solutions, Inc. As the head of the company, Roberts is responsible for overseeing the development and marketing of the company's payment system for medical cannabis transactions.
Track Record: Due to limited information, Jeremy Roberts' specific achievements and strategic decisions at Medical Cannabis Payment Solutions, Inc. cannot be determined. His track record is pending further evaluation as the company navigates the evolving medical cannabis payment landscape.
REFG OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Medical Cannabis Payment Solutions, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may be subject to less regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries a higher degree of risk due to the potential for limited information and increased volatility.
- OTC Tier: OTC Other
- Limited Financial Disclosure: The lack of available financial information makes it difficult to assess the company's financial health and performance.
- Low Liquidity: The low trading volume can lead to significant price volatility and difficulty in executing trades.
- Regulatory Uncertainty: The medical cannabis industry is subject to changing regulations, which could impact REFG's business.
- Going Concern Risk: The company's ability to continue as a going concern is uncertain given its lack of profitability and limited resources.
- Dilution Risk: The company may need to raise additional capital through equity offerings, which could dilute existing shareholders' ownership.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their experience.
- Assess the company's competitive landscape and market position.
- Evaluate the company's technology and intellectual property.
- Understand the regulatory risks associated with the medical cannabis industry.
- Monitor the company's news and press releases for any updates.
- Consult with a financial advisor before investing.
- Company is incorporated in Wyoming since 2013.
- The company has a website and actively markets its services.
- The company is focused on a specific niche market (medical cannabis payments).
- The company aims to address regulatory compliance in the cannabis industry.
Common Questions About REFG (Healthcare)
What do analysts say about REFG stock?
As of March 15, 2026, there is no available analyst coverage for Medical Cannabis Payment Solutions, Inc. (REFG). Given its OTC listing and small market capitalization, the company is not widely followed by analysts.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data available for Medical Cannabis Payment Solutions, Inc.
- OTC stocks carry higher risk than exchange-listed stocks.
- The medical cannabis industry is subject to regulatory changes.